Back to search
Molecular Surveillance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Molecular Surveillance trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Molecular Surveillance trials you may qualify forThe aim of this study is to lay the bases for an ambitious project that reports and records all the epidemiological-clinical information of the cases of endomet…
This is a Phase II, interventional, prospective, single-arm, multi-center study that will enroll patients with stage II/III triple negative breast cancer (TNBC)…
The goal of this clinical trial is to learn whether close microbiological monitoring without preventive antibiotics works as well as preventive treatment with c…
This study will prospectively monitor cancer patients receiving chemotherapy (including molecular targeted therapies) for cardiovascular adverse events using bi…
Hypervirulent and multidrug-resistant infections are associated with significant health care costs, substantial morbidity and mortality. Therefore, the rapid re…
Urothelial carcinomas are one of the most commonly diagnosed cancers worldwide. Postoperative patients carry a poor prognosis with an estimated five-year diseas…
Li-Fraumeni Syndrome (LFS) is a cancer predisposition disorder in which most affected individuals develop cancer during their lifetime. The majority of LFS pati…
Thyroid cancer is the most common endocrine malignancy, and although differentiated thyroid cancer (DTC) generally confers favorable outcomes, 10-20% of patient…
To learn about changes in ctDNA during the diagnosis, treatment, and post-treatment surveillance of EBC.